GN
Genelux Corporation (GNLX)
NASDAQ·Healthcare·Biotechnology
$2.01
+10.16%
Mkt Cap $88.68M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
Implied Upside
+764.3%
Consensus $17.33 vs current $2.01
NASDAQ·Healthcare·Biotechnology
$2.01
+10.16%
Mkt Cap $88.68M
No recent rating data.
Price Target (3 analysts)
$17.33
Range $16.00 – $20.00
+764.3%
Consensus $17.33 vs current $2.01